Emergent Biosolutions Canada Inc.
Records under this name other than patents Emergent Biosolutions Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Emergent Biosolutions Canada Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,117,933 | Antibodies against Clostridium difficile Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,751,919 | ANTIMICROBIAL COMPOSITIONS COMPRISING A HYALURONIC ACID BINDING PEPTIDE AND A beta-LACTAM ANTIBIOTIC Lapsed on the fee record Ended Sep 5, 2025 · High confidence | Lapsed on the fee record | Ended Sep 5, 2025 | High confidence |
| US 9,994,630 | Clostridium difficile antibodies Lapsed on the fee record Ended Jun 12, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2022 | From the USPTO record |
| US 9,505,847 | Clostridium difficile antibodies Lapsed on the fee record Ended Nov 29, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 29, 2020 | From the USPTO record |